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Reducing the number of sputum samples examined 
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smear microscopy
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SUMMARY
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SETTING: Urban health clinic, Nairobi.
OBJECTIVE: To evaluate the impact on tuberculosis
(TB) case detection and laboratory workload of reduc-
ing the number of sputum smears examined and thresh-
olds for diagnosing positive smears and positive cases.
DESIGN: In this prospective study, three Ziehl-Neelsen
stained sputum smears from consecutive pulmonary TB
suspects were examined blind. The standard approach
(A),  2 positive smears out of 3, using a cut-off of 10
acid-fast bacilli (AFB)/100 high-power ﬁelds (HPF), was
compared with approaches B,  2 positive smears ( 4
AFB/100 HPF) out of 3, one of which is  10 AFB/100
HPF; C,  2 positive smears ( 4 AFB/100 HPF) out of 3;
D,  1 positive smear ( 10 AFB/100 HPF) out of 2; and
E,  1 positive smear ( 4 AFB/100 HPF) out of 2. The
microscopy gold standard was detection of at least one
positive smear ( 4 AFB/100 HPF) out of 3.
RESULTS: Among 644 TB suspects, the alternative ap-
proaches detected from 114 (17.7%) (approach B) to
123 cases (19.1%) (approach E) compared to 105 cases
(16.3%) for approach A (P   0.005). Sensitivity ranged
between 82.0% (105/128) for A and 96.1% (123/128)
for E. The single positive smear approaches reduced the
number of smears by 36% compared to approach A.
CONCLUSION: Reducing the number of specimens and
the positivity threshold to deﬁne a positive case increased
the sensitivity of microscopy and reduced laboratory
workload.
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TUBERCULOSIS (TB) care that includes effective de-
tection and treatment of patients is central to the
global TB control strategy. Currently available diag-
nostics are either insensitive, time-consuming or re-
quire laboratory infrastructures that are considerably
more sophisticated than those commonly found in the
developing countries where TB burdens are highest.
There is an urgent need for a new TB diagnostic test
that is simple, rapid, sensitive and speciﬁc and can be
made widely available. The test development pipeline
is unlikely to deliver a test with such a proﬁle in the
short term.1 A recently developed model to evaluate
the potential role of better diagnostics in improving
TB control in developing countries has predicted that
improving the performance of sputum smear micros-
copy and reducing the loss of patients during the di-
agnostic process would be associated with consider-
able public health impact.2
Pulmonary TB patients with more than 105 My-
cobacterium tuberculosis organisms per ml of spu-
tum (approximately half of all pulmonary TB patients
worldwide) can be diagnosed using direct sputum smear
microscopy. International guidelines recommend the
microscopic examination of three serial sputum spec-
imens for acid-fast bacilli (AFB) in the investigation
of pulmonary TB suspects, and deﬁne a positive case
as a case with at least two smear-positive results.3–5
The ﬁrst specimen is a ‘spot’ specimen collected when
the patient presents at the health facility. The second
is an ‘early morning’ specimen collected at home, and
the third a further ‘spot’ specimen collected when the
patient returns to the health facility to deliver the early
morning specimen. At least one further visit to the
health facility is usually required for the patient to col-
lect the smear results.
Smear microscopy as currently recommended is as-
sociated with two major problems: variable sensitiv-
ity in detecting smear-positive cases, and a high rate
of patient drop-out during the diagnostic process.6,7
A systematic review has demonstrated that the aver-
age incremental yield and/or increase in sensitivity of
examining a third sputum specimen ranged from 2%
to 5%, and concluded that reducing the number of spec-
imens examined from three to two (and particularly
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to two specimens collected on the same day) could
potentially increase case detection.8 It was suggested
that this could be achieved by reducing the workload
in over-burdened laboratories and the number of pa-
tient visits required. Limitations of the review, as iden-
tiﬁed by the authors, were that few studies were blinded
or reported microscopy quality assurance, thresholds
for deﬁning a positive smear or the nature of the spu-
tum specimens (i.e., whether a specimen was a ﬁrst spot,
morning or second spot specimen). Recent studies have
shown the high speciﬁcity of single positive smear re-
sults and/or scanty smear results in high TB prevalence
settings.9,10 These studies have not as yet inﬂuenced
policy change with regard to international guidelines
on the deﬁnitions of a smear-positive case.
We prospectively evaluated different approaches
to sputum smear microscopy based on the examina-
tion of two and three specimens, with differing deﬁni-
tions of a ‘smear-positive’ case. In so doing we sought
to avoid the methodological deﬁciencies of many pre-
vious studies that were identiﬁed by the authors of the
afore-mentioned systematic review.8 We considered
the effect of the different approaches on case detec-
tion, laboratory workload and diagnostic delay.
STUDY POPULATION AND METHODS
The present study was conducted in an urban human
immunodeﬁciency virus (HIV)-TB health clinic sup-
ported by Médecins Sans Frontières in Mathare, a
slum area of Nairobi, Kenya. The clinic’s laboratory
routinely performs sputum smear microscopy. All con-
secutive patients aged  15 years with cough  2 weeks
were eligible for the study. After providing written in-
formed consent, patients submitted three sputum spec-
imens over 2 consecutive days. The ﬁrst specimen was
collected on the spot at the initial consultation, the
second at early morning and the third on the spot when
the patient delivered the morning specimen. The hot
Ziehl-Neelsen method (carbol-fuchsin 1%) was used.
Slides were examined using bright-ﬁeld microscopy
(magniﬁcation   1000) by two independent labora-
tory technicians blinded to the result of the previous
smear. The exact number of AFB observed in 100
high power ﬁelds (HPF) for each smear result was re-
corded on a separate laboratory form. Results were
then recorded independently in the programme labo-
ratory register by the study supervisor. Several ap-
proaches to sputum smear microscopy for the detec-
tion of smear-positive TB cases were compared (Table
1). The approaches varied in the AFB cut-off used to
deﬁne a positive smear, the number of positive smears
required to deﬁne a smear-positive case and whether
two or three specimens were examined.
Treatment of TB suspects referred to the laboratory
by the clinicians was decided based on microscopy re-
sult, clinical presentation and chest X-ray ﬁndings.
Every month the study supervisor blindly rechecked
50% to 100% of positive and 10% to 20% of ran-
domly selected negative slides. An external quality as-
sessment of 100 randomly selected slides at the end of
the study was performed blind at the TB laboratory
of the Centre for Respiratory Diseases Research of the
Kenyan Medical Research Institute (KEMRI), Nairobi,
Kenya. Inter-reader and intra-reader reliability was
assessed on a sample of 200 smears randomly selected
to be reread blind by the second reader or by the same
reader at 1-day intervals.
Data were double-entered using EpiData 3.1 (Epi-
Data, Odense, Denmark, www.epidata.org). Intention
to treat analysis was performed using SPSS® 11.0 for
Windows (SPSS Inc., Chicago, IL, USA).
The smear-positive case detection rate was calcu-
lated for each approach and compared between the
alternative approaches (B to E) and the standard ap-
proach (A), using McNemar’s test to compare matched
data. The performance of the different approaches was
measured using the detection of at least one smear with
 4 AFB/100 HPF out of three smears as the microscopy
‘gold standard’, based on the very good correlation
with culture results reported in previous studies.10,12
The detection yield of the ﬁrst smear and the incre-
mental yield of the second smear compared to the ﬁrst
smear and of the third smear compared to the ﬁrst two
smears were calculated as the ratio of the number of
cases with ﬁrst smear positive, ﬁrst smear negative
and second smear positive, and two ﬁrst smears neg-
ative and third smear positive, divided by the total
number of cases with at least one positive smear out
of three examined. The smear-positive detection rate
of the second, early morning, specimen was compared
with that of the third, on-the-spot, specimen, which
was prepared together with the second specimen.
Inter-reader and intra-reader reliability was assessed
by the calculation of the Kappa coefﬁcient, which mea-
sures the extent to which the results of both tests vary
when read by two independent readers or at a 1-day
interval by the same reader. A   value between 0.80
and 1 signiﬁes almost perfect agreement.
The mean time between initial consultation and
ﬁnal smear results and the total number of slides read
per approach were calculated.
Table 1 Deﬁnitions of smear-positive cases according to the 
different smear microscopy approaches used in the study
Approach A3,4 At least 2 smear-positive results out of 3, using a 
cut-off of 10 AFB/100 HPF
Approach B5 At least 2 smear-positive results ( 4 AFB/100 HPF)
out of 3, one of which being  10 AFB/100 HPF
Approach C11 At least 2 smear-positive results out of 3, using a 
cut-off of 4 AFB/100 HPF
Approach D At least 1 smear-positive result out of the 2 first 
specimens collected, using a cut-off of 
10 AFB/100 HPF
Approach E At least 1 smear-positive result out of the 2 first 
specimens collected, using a cut-off of
4 AFB/100 HPF
AFB   acid-fast bacilli; HPF   high power ﬁelds.One, two or three smears? 955
The study was approved by the Ethical Review
Committees of KEMRI (Nairobi, Kenya) and the
‘Comité de Protection des Personnes’, Saint Germain-
en-Laye, France.
RESULTS
Between February and December 2005, 644 patients
were included in the study (Figure), resulting in the
examination of 1879 specimens. The mean age was
32 years (standard deviation [SD] 10.3) and the male/
female sex ratio was 0.8 (287/356). One hundred and
twenty one patients (18.8%) had a past history of TB
and 37 (5.7%) had received broad-spectrum antibiot-
ics in the 2 weeks before sputum investigation. In ad-
dition to cough, 593 patients had a history of fever
(92.5%), 596 (92.5%) chest pain, 109 (16.9%) hae-
moptysis, 245 (38.0%) reported weight loss and 484
(75.2%) had loss of appetite. Of the 644 patients, 614
(95.3%) were able to produce three sputum specimens,
7 (1.1%) two and 23 (3.6%) only one.
Of the 1879 specimens, 1401 (74%) were macro-
scopically purulent or muco-purulent, 414 (22.0%)
were mucoid, 30 were blood-stained (3.0%) and 8 sal-
ivary (0.4%). A ﬁnal total of 1855 (98.7%) good qual-
ity smears were deﬁned microscopically by the presence
of blue cellular elements without debris or artifacts.
Standard approach A detected 105 smear-positive
cases (16.3%). Smear-positive detection of the alter-
native approaches B to E is reported in Table 2. All
detected signiﬁcantly more smear-positive cases than
approach A. The microscopy gold standard detected
a total of 128 smear-positive cases. The performance
of the different approaches is presented in Table 3. D
and E were the most sensitive approaches.
Using a cut-off of 10 and 4 AFB/100 HPF, re-
spectively 120 and 128 patients were detected with at
least one smear-positive result out of three examined.
The incremental detection yield of the ﬁrst, second
and third specimen is shown in Table 4. Regardless of
the cut-off, the incremental yield of the second smear
compared to the ﬁrst smear was signiﬁcant (P   0.001).
This was not the case for the incremental yield of the
third smear compared to the two ﬁrst smears (P  
0.25 for 10 AFB/100 HPF and P   0.06 for 4 AFB/
100 HPF).
The smear-positive detection yield of the morning
specimen (using 10 AFB/100 HPF cut-off) was 18.4%
(114/621) compared to 14.2% (88/621) for the third
specimen (P   0.001). Of the 26 cases detected as pos-
itive only after examination of the morning specimen,
23 (88.5%) had scanty results (1–9 AFB/100 HPF)
after examination of the third (on-the-spot) specimen.
Using 4 AFB/100 HPF as the cut-off, the detection yield
of the morning specimen was 19.0% (118/621) com-
pared to 17.6% (109/621) for the third specimen; the
difference was not signiﬁcant (P   0.06). Of nine cases
detected as positive only after examination of the sec-
ond specimen, 6 (66.7%) had 1–3 AFB/100 HPF after
examination of the third specimen.
Figure Study proﬁle. ICF   informed consent form.
Table 2 Smear-positive case detection rates of the different 













Approach A 105 (16.3)
Approach B 114 (17.7) 0.004 9/105 (8.6)
Approach C 115 (17.9) 0.002 10/105 (9.5)
Approach D 117 (18.2)  0.001 12/105 (11.4)
Approach E 123 (19.1)  0.001 18/105 (17.1)
WHO   World Health Organization.
Table 3 Performance of the different approaches for 
detecting smear-positive TB cases using at least one positive 












Approach A 105 82.0 100 100 95.7
Approach B 114 89.1 100 100 97.4
Approach C 115 89.8 100 100 97.5
Approach D 117 91.4 100 100 97.9
Approach E 123 96.1 100 100 99.0
TB   tuberculosis; AFB   acid-fast bacilli; HPF   high power ﬁelds; PPV  
positive predictive value; NPV   negative predictive value.
Table 4 Smear microscopy incremental yield of the ﬁrst, 
second and third specimen using one positive smear to deﬁne 























10 AFB/100 HPF 120 88 (73.3) 29 (24.7) 3 (2.5)
4 AFB/100 HPF 128 109 (85.2) 14 (10.9) 5 (3.9)
AFB   acid-fast bacilli; HPF   high power ﬁelds.956 The International Journal of Tuberculosis and Lung Disease
The mean time between the initial consultation and
the ﬁnal smear results was 1.6 days (SD 2.9) using ap-
proaches D and E based on collection of two specimens,
compared to 2.0 days (SD 3.4) with approaches A–C
based on collection of three specimens (P   0.001).
Inter-reader and intra-reader reliability were very
good, with a   coefﬁcient of 0.83 (95% conﬁdence in-
terval [CI] 0.76–0.86) and 0.91 (95%CI 0.88–0.94),
respectively. The sensitivity of the monthly quality con-
trol ranged between 92% and 100% and speciﬁcity be-
tween 95% and 100%. There was no positive/negative
discordance and only one scanty result controlled as
negative in the external quality control.
The three-specimen based approaches (A, B, C) re-
sulted in the reading of 1879 slides (644   621   614).
The two-specimen based approaches D and E resulted
in the reading of 1200 (644   [644   88]) and 1179
slides (644   [644   109]), respectively, which re-
duced by 36.1% (679/1879) and 37.2% (700/1932)
the number of slides to be read compared to the three-
specimen based approaches.
DISCUSSION
Adopting an approach based on two specimens and
deﬁning a smear-positive patient as having at least one
positive smear result, regardless of AFB cut-off, would
increase smear-positive case detection signiﬁcantly
compared to the use of the standard approach based
on two smear-positive results out of three specimens.
A national survey in Indonesia recently reported an
increase in prevalence of smear-positive cases from
104 to 120 per 100000 population using one positive
smear instead of two to deﬁne a positive case.13
The addition of the third sputum smear did not sig-
niﬁcantly increase the detection of smear-positive
cases: the incremental yield of the third compared to
the two ﬁrst sputum samples was in the range of 2%
to 5%, as reported in a recent systematic review.8 A
recent retrospective laboratory registers-based study
in Mongolia and Zimbabwe reported 0.7–4.5% sus-
pects detected with a positive result only on the third
smear examination.14 Better smear-positive detection
was reported on the early morning specimen com-
pared to the on-the-spot specimen, as has already been
shown elsewhere, but was statistically non-signiﬁcant
when a smear-positive result was deﬁned by the detec-
tion of  4 AFB /100 HPF.15 In our study, the increase
in detection was mainly the consequence of a better
concentration of AFB in the morning specimen and
was therefore more signiﬁcant when using a higher
AFB cut-off. With the use of 4 AFB/HPF cut-off, our
results are consistent with the results of a recent study
that assessed the diagnostic yield of the examination
of two sputum specimens collected on a single day at
the initial consultation against the standard 2-day ap-
proach, and did not report a signiﬁcantly different
smear-positive case detection rate.6
The use of a 4 AFB/100 HPF cut-off to deﬁne a
positive smear result rather than a 10 AFB cut-off in-
creased smear-positive case detection. Due to the ab-
sence of a culture gold standard in our study, we used
4 AFB/100 HPF as the cut-off rather than 1 AFB/100
HPF because previous studies in similar settings re-
ported a good correlation between culture results and
smear results with  4 AFB when good, quality-assured
microscopy was in place, even in high HIV-prevalence
settings.9,10,16
This was the case in our study, in which the high
inter-reader reliability and good results of the quality
controls support the high quality of the smear micros-
copy. Our choice of AFB cut-off was strengthened by
the low rate of false-positive smear results (54/3830,
1.4%) reported by the very large study conducted in
1980 in four Eastern African laboratories assessing
the true speciﬁcity of smear microscopy by examina-
tion of spiked artiﬁcial specimens.17 Nevertheless, the
use of a more sensitive cut-off (4 AFB/100 HPF) com-
pared to the standard 10 AFB cut-off may not result
in more patients started on TB treatment under rou-
tine programme conditions, where patients with only
scanty results are treated anyway, even if they are re-
ported as being smear-negative.
In ideal conditions, when smears can be read on
the day of specimen collection, an approach using a
case deﬁnition based on one positive smear would re-
sult in two thirds of smear-positive patients starting
treatment on the ﬁrst visit. This may be valuable, given
that some national TB programmes report patient
drop-out rates during the diagnostic phase of as high
as 37%.18 The time between initial consultation and
ﬁnal smear result was reduced using approaches based
on two smear examinations compared to those with
three smears. However, the translation of these shorter
times to smear results into earlier treatment start
was not addressed in this study, and requires further
investigation.
In the present study, approaches based on two spu-
tum specimens resulted in a signiﬁcant reduction in
the number of smears compared to those based on the
collection of three specimens. This could alleviate the
overwhelming workload of laboratories, particularly
in countries with high HIV prevalence, which have
experienced both a dramatic increase in TB cases and
a human resource crisis. Reducing the number of spu-
tum smears that need to be examined by one third
would allow more time for examination of the remain-
ing smears, may impact positively on the quality of
smear microscopy and would ﬁnally increase the
number of smear-positive TB cases detected. In addi-
tion, dropping the third smear will lead to a signiﬁ-
cant reduction in costs.19,20
In conclusion, the approach using one positive smear
result after examination of two specimens in a high
HIV prevalence setting increases the sensitivity of the
method and reduces both the laboratory workloadOne, two or three smears? 957
and diagnostic delays. Lowering the AFB threshold to
deﬁne a smear-positive case would increase the number
of smear-positive cases detected, and could be consid-
ered in settings with quality-assured smear microscopy.
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RÉSUMÉ
CONTEXTE: Centre de santé urbain, Nairobi.
OBJECTIVE: Evaluer l’impact de la réduction du nombre
de crachats examinés et du seuil de positivité pour dé-
finir un frottis positif sur le taux de détection et la charge
de travail au laboratoire.
DESIGN : Etude prospective. Examen microscopique
(Ziehl-Neelsen) à l’aveugle de trois crachats de patients
consécutifs suspects de tuberculose. La méthode stan-
dard (A),  2 frottis positifs sur 3, en utilisant un seuil de
10 bacilles acido-résistants (BAAR)/100 champs micro-
scopiques (CM) a été comparée avec B,   2 frottis posi-
tifs ( 4 BAAR/100 CM) sur 3, un étant  10 BAAR/
100 CM ; C,  2 frottis positifs ( 4 BAAR/100 CM) sur
3 ; D,  1 frottis positif ( 10 BAAR/100 CM) sur 2 ; et
E,  1 frottis positif ( 4 BAAR/100 CM) sur 2. La dé-
tection d’au moins 1 frottis positif ( 4 BAAR/100 CM)
sur 3 était l’examen microscopique de référence.
RÉSULTS : Sur 644 suspects, les approches alternatives B
et E ont détecté entre 114 (17,7%) et 123 cas (19,1%)
par rapport à 105 cas (16,3%) pour A (P   0,005). La
sensibilité variait entre 82,0% (105/128) pour A et 96,1%
(123/128) pour E. Les approches basées sur un frottis
positif réduisaient de 36% le nombre de frottis par rap-
port à l’approche A.
CONCLUSION: La réduction du nombre de crachats et
du seuil de positivité a augmenté la sensibilité de la mi-
croscopie et diminué la charge de travail.958 The International Journal of Tuberculosis and Lung Disease
RESUMEN
MARCO DE REFERENCIA: Dispensario urbano en
Nairobi.
OBJETIVO: Evaluación de la repercusión de una reduc-
ción de la cantidad de muestras de esputo examinadas y
de los valores discriminatorios que definen las bacilo-
scopias positivas y los casos de tuberculosis (TB) sobre
la detección de casos y el volumen de trabajo de los
laboratorios.
MÉTODO : Estudio prospectivo con anonimato en el cual
se examinaron, mediante coloración de Ziehl-Neelsen,
tres muestras de esputo de cada paciente consecutivo con
presunción clínica de TB. La estrategia (A),  2 bacilo-
scopias positivas de un total de 3, con un valor discrimi-
natorio de 10 bacilos acidorresistentes (BAAR) por 100
campos con objetivo de gran aumento (CGA), se com-
paró con B,  2 baciloscopias positivas de 3, con  4
BAAR/100 CGA, una de las cuales con  10 BAAR/100
CGA ; C, 2 o 3 baciloscopias positivas de 3, con  4
BAAR/100 CGA ; D,  1 baciloscopias positivas de 2,
con  10 BAAR/100 CGA ; y con E,  1 baciloscopias
positivas de 2, con  4 BAAR/100 CGA . El rendimiento
diagnóstico se comparó con la estrategia de referencia :
por lo menos 1 baciloscopia positiva de un total de 3
( 4 BAAR/100 CGA).
RESULTADOS: En los 644 casos con presunción diagnó-
stica de TB, se detectaron entre 114 casos (17,7%) con
la estrategia B y 123 casos (19,1%) con la estrategia E,
en comparación con 105 casos (16,3%) detectados con
la estrategia A (P   0,005). La sensibilidad osciló entre
82,0% (105/128) con la estrategia A y 96,1% (123/128)
con la estrategia E. La supresión de una muestra de es-
puto disminuyó de 36% la cantidad de baciloscopias exa-
minadas, en comparación con la estrategia de base A.
CONCLUSIÓN: La reducción de la cantidad de muestras
y del umbral de positividad con el fin de definir un caso
de tuberculosis aumenta la sensibilidad y reduce el volu-
men de trabajo de los laboratorios.